J Clin Neurol.  2009 Dec;5(4):195-197. 10.3988/jcn.2009.5.4.195.

A Case of Cerebral Venous Thrombosis as the Presenting Sign of Occult Prostate Cancer

• Lee SS
• Baek SH
• Shin DI

• KMID: 2287650
• DOI: http://doi.org/10.3988/jcn.2009.5.4.195

Abstract

BACKGROUND
Cerebral venous thrombosis (CVT) is a distinct disorder with highly variable symptoms and courses. Malignancy is known to be one of the predisposing factors of CVT. CASE REPORT: We present the case of a 69-year-old man with sudden behavioral changes. Brain MRI, magnetic resonance venography, and positive D-dimer assay confirmed the presence of CVT. The work-up for detecting the cause of the CVT revealed occult prostate cancer. CONCLUSIONS: Occult malignancy including prostate cancer should be strongly suspected in older patients with idiopathic CVT.

Keyword

cerebral venous thrombosis; D-dimer; prostate cancer

MeSH Terms

Aged
Brain
Fibrin Fibrinogen Degradation Products
Humans
Magnetic Resonance Spectroscopy
Phlebography
Prostate
Prostatic Neoplasms
Venous Thrombosis
Fibrin Fibrinogen Degradation Products

Figure

• 

  Fig. 1 Brain MRI and magnetic resonance (MR) venography (AP view). A: Hemorrhagic infarction was noted in the left parietal lobe on T2-weighed imaging. B: MR venography showed occlusion of the left transverse sinus.

Reference

1. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005. 352:1791–1798.

2. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007. 6:162–170.

3. Khorana A, Fine R. Pancreatic cancer and thromboembolic disease. Lancet Oncol. 2004. 5:655–663.

4. Zhang Y, Deng Y, Luther T, Müller M, Ziegler R, Waldherr R, et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest. 1994. 94:1320–1327.

5. Oefelein MG, Brant M, Crotty K. Idiopathic thromboembolism as the presenting sign of occult prostate cancer. Urology. 1998. 51:775–780.

6. White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D, et al. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med. 2005. 165:1782–1787.

7. Hettiarachchi RJ, Lok J, Prins MH, Büller HR, Prandoni P. Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis. Cancer. 1998. 83:180–185.

8. Cornuz J, Pearson SD, Creager MA, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann Intern Med. 1996. 125:785–793.

9. Tardy B, Tardy-Poncet B, Viallon A, Piot M, Garnier P, Mohamedi R, et al. D-dimer levels in patients with suspected acute cerebral venous thrombosis. Am J Med. 2002. 113:238–241.

10. Ferro JM, Canhão P, Bousser MG, Barinagarrementeria F. ISCVT Investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005. 36:1927–1932.